On this page we presented the RARE historical earnings date information for Ultragenyx Pharmaceutical. Reviewing that RARE Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2020, when RARE posted gaap of -0.370/share. Meanwhile the lowest RARE historical earnings result was in Q3 2022, when RARE posted gaap of -2.430/share. Moving to Ultragenyx Pharmaceuticals historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2024 when RARE reported 0.15B in revenue, while the smallest revenue quarter was Q2 2017 when RARE reported NA in revenue.

For self directed investors doing their due diligence on RARE or any other given stock, their research can benefit from looking into all of the Ultragenyx Pharmaceutical historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Ultragenyx Pharmaceutical historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for RARE. Thanks for visiting, and the next time you need to research RARE historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.